| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 142 | +68.31% | +5.06% | +1.12% | +3.95% | +7.47% | 2.77 |
| 14d | 142 | +59.86% | +1.46% | +1.57% | -0.11% | -0.44% | -0.06 |
| 30d | 142 | +59.15% | +6.12% | +2.70% | +3.42% | +9.25% | 1.87 |
| 60d | 142 | +71.13% | +13.89% | +4.01% | +9.88% | +15.81% | 3.31 |
| 90d | 142 | +69.01% | +7.18% | +4.67% | +2.51% | +9.98% | 0.86 |
| 180d | 142(1 pending) | +56.74% | +11.09% | +8.79% | +2.51% | -3.56% | 0.48 |
| 1y | 142(8 pending) | +23.13% | -25.90% | +21.22% | -47.12% | -54.25% | -10.03 |
| 2y | 142(30 pending) | +32.14% | -13.21% | +39.60% | -52.81% | -68.73% | -8.56 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,675 | — | — | 31,675 | Jun 16, 2026 | Jun 18, 2026 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | SALE | 109,331 | $89.50 | $9.79M | 950,000 | Apr 28, 2026 | Apr 30, 2026 ↗ | View → |
| HLXC HELIX ACQUISITION CORP. III | PURCHASEGRANT Stock grant | 497,500 | $10.00 | $4.97M | 497,500 | Jan 26, 2026 | Jan 26, 2026 ↗ | View → |
| HLXC HELIX ACQUISITION CORP. III | PURCHASE Chairperson and CEO | 800,000 | $10.00 | $8.00M | 800,000 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| HLXC HELIX ACQUISITION CORP. III | PURCHASEGRANT Stock grant | 497,500 | $10.00 | $4.97M | 497,500 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| HLXC HELIX ACQUISITION CORP. III | PURCHASE Chairperson and CEO | 718,750 | — | — | 4,252,500 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| HLXC HELIX ACQUISITION CORP. III | PURCHASE Chairperson and CEO | 718,750 | — | — | 4,252,500 | Jan 22, 2026 | Jan 28, 2026 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | SALE | 30,029 | $11.46 | $344.0K | 2,344,971 | Dec 11, 2025 | Dec 15, 2025 ↗ | View → |
| EYPT EYEPOINT, INC. | SALE | 60,000 | $15.70 | $942.2K | 8,265,000 | Dec 4, 2025 | Dec 8, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 5,827 | $6.96 | $40.6K | 1,994,173 | Sep 30, 2025 | Oct 1, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 232,460 | $8.40 | $1.95M | 8,190,943 | Sep 29, 2025 | Oct 1, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 70,748 | $9.38 | $663.6K | 8,423,403 | Sep 29, 2025 | Oct 1, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 2,800,000 | $6.61 | $18.51M | 2,000,000 | Sep 29, 2025 | Oct 1, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 3,390,943 | $7.58 | $25.70M | 4,800,000 | Sep 29, 2025 | Oct 1, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,905,046 | — | — | 1,905,046 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASE | 4,172,126 | — | — | 4,681,126 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,762,760 | — | — | 3,305,470 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 284,571 | — | — | 5,952,356 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | SALE | 307,874 | — | — | 4,172,126 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | SALE | 4,172,126 | — | — | 0 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | SALE | 152,940 | — | — | 4,528,186 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,598,425 | $10.72 | $60.00M | 5,667,785 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 639,110 | $10.72 | $6.85M | 1,542,710 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 760,496 | $10.72 | $8.15M | 2,187,536 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASEGRANT Stock grant | 91,970 | — | — | 91,970 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE | 1,813,439 | $1.85 | $3.36M | 0 | May 15, 2025 | May 19, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE | 24,300 | $1.99 | $48.2K | 1,813,439 | May 12, 2025 | May 14, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE | 187,500 | $16.00 | $3.00M | 987,689 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | SALE | 6,780,810 | — | — | 0 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE | 800,189 | — | — | 800,189 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 184,331 | $21.70 | $4.00M | 1,059,331 | Nov 4, 2024 | Nov 6, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 39,743 | $23.22 | $922.6K | 864,743 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 3,107 | $25.22 | $78.4K | 875,000 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 7,150 | $24.03 | $171.8K | 871,893 | Oct 16, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 2,700 | $9.26 | $25.0K | 801,222 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 8,900 | $7.31 | $65.0K | 795,922 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 238,097 | $4.53 | $1.08M | 690,506 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 19,169 | $11.72 | $224.6K | 820,391 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 63,173 | $5.92 | $374.2K | 753,679 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 2,600 | $8.80 | $22.9K | 798,522 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 4,609 | $12.35 | $56.9K | 825,000 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| DRUG BRIGHT MINDS BIOSCIENCES INC. | PURCHASE | 33,343 | $6.42 | $214.2K | 787,022 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| BIOA BIOAGE LABS, INC. | PURCHASE | 1,179,529 | — | — | 1,179,529 | Sep 27, 2024 | Oct 1, 2024 ↗ | View → |
| BIOA BIOAGE LABS, INC. | SALE | 5,263,772 | — | — | 0 | Sep 27, 2024 | Oct 1, 2024 ↗ | View → |
| BIOA BIOAGE LABS, INC. | PURCHASE | 450,000 | $18.00 | $8.10M | 1,629,529 | Sep 27, 2024 | Oct 1, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 25,943 | $18.36 | $476.3K | 2,096,028 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 139,551 | $20.42 | $2.85M | 2,301,667 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 66,088 | $19.61 | $1.30M | 2,162,116 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 47,564 | $21.47 | $1.02M | 2,349,231 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 45,085 | $17.48 | $787.9K | 2,070,085 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 25,769 | $22.23 | $572.8K | 2,375,000 | Sep 20, 2024 | Sep 24, 2024 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASEGRANT Stock grant | 51,025 | — | — | 51.025 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 207,153 | $12.36 | $2.56M | 8,325,000 | May 6, 2024 | May 8, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 642,847 | $11.70 | $7.52M | 8,117,847 | May 6, 2024 | May 8, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 395,244 | $17.62 | $6.96M | 7,288,479 | Apr 18, 2024 | Apr 22, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 186,521 | $18.90 | $3.53M | 7,475,000 | Apr 18, 2024 | Apr 22, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 10 | $3.01 | $30 | 3,294,163 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 300 | $3.07 | $920 | 3,294,873 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 100 | $3.05 | $305 | 3,294,773 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 10 | $2.98 | $30 | 3,294,153 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 280 | $2.97 | $832 | 3,293,873 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 100 | $3.07 | $307 | 3,295,173 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 600 | $3.03 | $1.8K | 3,294,173 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 398,600 | $2.90 | $1.16M | 2,895,273 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 400,000 | $2.14 | $856.4K | 3,295,273 | Mar 15, 2024 | Mar 18, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 98,570 | $4.25 | $418.4K | 3,760,528 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 54,215 | $5.37 | $291.4K | 3,706,313 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 345,266 | $3.24 | $1.12M | 3,859,098 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 11,040 | $5.97 | $65.9K | 3,695,273 | Mar 14, 2024 | Mar 18, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 24,983 | $42.25 | $1.06M | 1,779,325 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 8,862 | $45.96 | $407.3K | 2,025,000 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 18,548 | $43.26 | $802.4K | 1,797,873 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 29,342 | $41.23 | $1.21M | 1,754,342 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 61,668 | $44.62 | $2.75M | 1,859,541 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 156,597 | $45.26 | $7.09M | 2,016,138 | Mar 8, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 10,736 | $39.13 | $420.1K | 1,532,535 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 46,799 | $37.82 | $1.77M | 1,521,799 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 102,140 | $41.23 | $4.21M | 1,725,000 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 90,325 | $39.99 | $3.61M | 1,622,860 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 750,000 | $19.00 | $14.25M | 1,475,000 | Feb 2, 2024 | Feb 6, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 14,388 | $25.73 | $370.2K | 456,756 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 36,747 | $27.70 | $1.02M | 508,746 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 16,484 | $36.53 | $602.2K | 678,046 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 32,295 | $35.83 | $1.16M | 661,562 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 3,200 | $38.49 | $123.2K | 725,000 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 31,549 | $34.62 | $1.09M | 629,267 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 3,866 | $32.47 | $125.5K | 579,663 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 4,125 | $31.86 | $131.4K | 575,797 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 15,243 | $26.66 | $406.4K | 471,999 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 18,055 | $33.71 | $608.6K | 597,718 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 2,654 | $31.00 | $82.3K | 571,672 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 29,244 | $29.42 | $860.4K | 569,018 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 43,754 | $37.49 | $1.64M | 721,800 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC. | PURCHASE | 31,028 | $28.82 | $894.2K | 539,774 | Jan 26, 2024 | Jan 30, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 750,000 | $19.75 | $14.81M | 6,893,235 | Jan 11, 2024 | Jan 11, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 105,000 | $21.32 | $2.24M | 6,143,235 | Jan 9, 2024 | Jan 11, 2024 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 588,235 | $17.00 | $10.00M | 6,038,235 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 39,899 | $24.87 | $992.3K | 5,105,366 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 15,582 | $30.74 | $479.0K | 5,293,337 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 18,601 | $29.91 | $556.4K | 5,277,755 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 79,805 | $21.87 | $1.75M | 5,000,296 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 27,425 | $27.87 | $764.3K | 5,250,986 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 321,259 | $18.80 | $6.04M | 3,852,202 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 53,109 | $26.73 | $1.42M | 5,223,561 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 945,664 | $19.88 | $18.80M | 4,797,866 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 8,260 | $34.49 | $284.9K | 5,450,000 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 37,081 | $24.01 | $890.3K | 5,065,467 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 65,086 | $25.88 | $1.68M | 5,170,452 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 122,625 | $20.62 | $2.53M | 4,920,491 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 8,168 | $28.78 | $235.1K | 5,259,154 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 86,713 | $31.83 | $2.76M | 5,380,050 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 41,824 | $33.08 | $1.38M | 5,421,874 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 28,090 | $22.80 | $640.5K | 5,028,386 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| EYPT EYEPOINT, INC. | PURCHASE | 19,866 | $33.75 | $670.5K | 5,441,740 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 58,839 | $59.90 | $3.52M | 8,494,151 | Oct 5, 2023 | Oct 10, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 67,814 | $57.32 | $3.89M | 8,435,312 | Oct 4, 2023 | Oct 4, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 150,487 | $57.25 | $8.62M | 8,367,498 | Oct 3, 2023 | Oct 4, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 74,911 | $57.37 | $4.30M | 8,217,011 | Oct 2, 2023 | Oct 4, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 800,000 | $50.00 | $40.00M | 4,927,100 | Jun 30, 2023 | Jul 5, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 21,823 | $53.98 | $1.18M | 4,102,304 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 417 | $60.21 | $25.1K | 4,126,614 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 85 | $72.46 | $6.2K | 4,127,100 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 18,949 | $54.92 | $1.04M | 4,121,253 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 8,697 | $52.01 | $452.3K | 4,075,756 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 31,558 | $44.23 | $1.40M | 3,940,881 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 10,946 | $44.93 | $491.8K | 3,951,827 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 1,894 | $56.89 | $107.7K | 4,124,600 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 17,662 | $50.77 | $896.7K | 4,067,059 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 15 | $70.62 | $1.1K | 4,127,015 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 10,593 | $39.17 | $414.9K | 3,692,929 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 1,302 | $58.98 | $76.8K | 4,126,197 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 66,087 | $43.30 | $2.86M | 3,909,323 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 139 | $63.85 | $8.9K | 4,126,889 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 59,787 | $49.82 | $2.98M | 4,049,397 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 37,783 | $48.93 | $1.85M | 3,989,610 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 50,642 | $41.03 | $2.08M | 3,782,194 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 4,725 | $52.81 | $249.5K | 4,080,481 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 136 | $62.20 | $8.5K | 4,126,750 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 38,623 | $39.87 | $1.54M | 3,731,552 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 295 | $57.63 | $17.0K | 4,124,895 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 1,481 | $36.91 | $54.7K | 3,678,581 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 1,453 | $55.83 | $81.1K | 4,122,706 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 61,042 | $42.12 | $2.57M | 3,843,236 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 16 | $65.32 | $1.0K | 4,127,000 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 3,755 | $38.18 | $143.4K | 3,682,336 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 95 | $64.44 | $6.1K | 4,126,984 | Jun 26, 2023 | Jun 28, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Jun 22, 2023 | Jun 26, 2023 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASEGRANT Stock grant | 6,989 | — | — | 6,989 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASE | 400,000 | $30.00 | $12.00M | 3,570,872 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 238,511 | $21.70 | $5.18M | 3,677,100 | Mar 21, 2023 | Mar 22, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 78,008 | $21.08 | $1.64M | 3,438,589 | Mar 20, 2023 | Mar 22, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 63,700 | $20.42 | $1.30M | 3,360,581 | Mar 20, 2023 | Mar 22, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 446,881 | $19.36 | $8.65M | 3,296,881 | Mar 20, 2023 | Mar 22, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 307,692 | $6.50 | $2.00M | 10,813,246 | Dec 13, 2022 | Dec 21, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 307,692 | $6.50 | $2.00M | 10,813,246 | Dec 13, 2022 | Jul 22, 2021 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASEGRANT Stock grant | 23,867 | — | — | 23,867 | Jun 22, 2022 | Jun 24, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 22, 2022 | Jun 24, 2022 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE | 2,785,000 | — | — | 0 | Apr 5, 2022 | Apr 7, 2022 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 2,850,000 | $10.00 | $28.50M | 2,850,000 | Apr 5, 2022 | Apr 7, 2022 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE | 2,785,000 | — | — | 3,215,000 | Apr 5, 2022 | Apr 7, 2022 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASE | 450,000 | $16.00 | $7.20M | 1,118,854 | Oct 13, 2021 | Oct 15, 2021 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | PURCHASE | 668,854 | — | — | 668,854 | Oct 13, 2021 | Oct 15, 2021 ↗ | View → |
| PYXS PYXIS ONCOLOGY, INC. | SALE | 668,854 | — | — | 0 | Oct 13, 2021 | Oct 15, 2021 ↗ | View → |
| TYRA TYRA BIOSCIENCES, INC. | SALE | 757,432 | — | — | 0 | Sep 17, 2021 | Sep 21, 2021 ↗ | View → |
| TYRA TYRA BIOSCIENCES, INC. | PURCHASE | 312,500 | $16.00 | $5.00M | 1,069,932 | Sep 17, 2021 | Sep 21, 2021 ↗ | View → |
| TYRA TYRA BIOSCIENCES, INC. | PURCHASE | 757,432 | — | — | 757,432 | Sep 17, 2021 | Sep 21, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 200,000 | $22.10 | $4.42M | 10,505,553 | Aug 10, 2021 | Aug 10, 2021 ↗ | View → |
| IMRX IMMUNEERING CORP | SALE | 1,702,628 | — | — | 0 | Aug 3, 2021 | Aug 5, 2021 ↗ | View → |
| IMRX IMMUNEERING CORP | PURCHASE | 1,702,628 | — | — | 1,702,628 | Aug 3, 2021 | Aug 5, 2021 ↗ | View → |
| IMRX IMMUNEERING CORP | PURCHASE | 550,000 | $15.00 | $8.25M | 2,252,628 | Aug 3, 2021 | Aug 5, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 200,000 | $18.77 | $3.75M | 10,305,553 | Jul 26, 2021 | Aug 10, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 9,555,553 | — | — | 9,555,553 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 4,166,666 | — | — | 0 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 950,000 | $16.00 | $15.20M | 10,505,553 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 4,000,000 | — | — | 0 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 1,388,887 | — | — | 0 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE | 477,857 | — | — | 0 | Jun 28, 2021 | Jun 30, 2021 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE | 600,000 | $19.00 | $11.40M | 3,202,200 | Jun 28, 2021 | Jun 30, 2021 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE | 2,602,200 | — | — | 2,602,200 | Jun 28, 2021 | Jun 30, 2021 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE | 2,124,343 | — | — | 0 | Jun 28, 2021 | Jun 30, 2021 ↗ | View → |
| RAIN RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. | PURCHASE | 450,000 | $17.00 | $7.65M | 2,776,657 | Apr 27, 2021 | Apr 29, 2021 ↗ | View → |
| RAIN RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. | SALE | 2,512,561 | — | — | 0 | Apr 27, 2021 | Apr 29, 2021 ↗ | View → |
| RAIN RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. | PURCHASE | 2,326,657 | — | — | 2,326,657 | Apr 27, 2021 | Apr 29, 2021 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASE | 900,000 | $17.00 | $15.30M | 3,170,872 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASE | 2,270,872 | — | — | 2,270,872 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | PURCHASE | 2,270,872 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| BMEA BIOMEA FUSION, INC. | SALEGRANT Stock grant | 28,911 | — | — | 28,911 | Apr 15, 2021 | Apr 19, 2021 ↗ | View → |
| DSGN DESIGN THERAPEUTICS, INC. | PURCHASE | 4,364,844 | — | — | 4,364,844 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| DSGN DESIGN THERAPEUTICS, INC. | SALE | 2,959,891 | — | — | 0 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| DSGN DESIGN THERAPEUTICS, INC. | SALE | 1,404,953 | — | — | 0 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| DSGN DESIGN THERAPEUTICS, INC. | PURCHASE | 750,000 | $20.00 | $15.00M | 5,114,844 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| BCAB BIOATLA, INC. | PURCHASE | 1,492,060 | — | — | 1,492,060 | Dec 18, 2020 | Dec 22, 2020 ↗ | View → |
| BCAB BIOATLA, INC. | SALE | 1,492,060 | — | — | 0 | Dec 18, 2020 | Dec 22, 2020 ↗ | View → |
| BCAB BIOATLA, INC. | PURCHASE | 800,000 | $18.00 | $14.40M | 2,292,060 | Dec 18, 2020 | Dec 22, 2020 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE | 2,122,367 | — | — | 0 | Nov 23, 2020 | Nov 23, 2020 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE | 723,177 | — | — | 0 | Nov 23, 2020 | Nov 23, 2020 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASE | 425,000 | $19.00 | $8.07M | 3,270,544 | Nov 23, 2020 | Nov 23, 2020 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASE | 2,845,544 | — | — | 2,845,544 | Nov 23, 2020 | Nov 23, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | SALE | 417,360 | — | — | 0 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | SALE | 1,000,000 | — | — | 0 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | SALE | 1,650,165 | — | — | 0 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | PURCHASE | 6,411,355 | — | — | 6,411,355 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | SALE | 712,250 | — | — | 0 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| AVIR ATEA PHARMACEUTICALS, INC. | SALE | 2,631,580 | — | — | 0 | Nov 3, 2020 | Nov 5, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 2,214,545 | — | — | 2,214,545 | Jun 16, 2020 | Jun 18, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 300,000 | $18.00 | $5.40M | 2,514,545 | Jun 16, 2020 | Jun 18, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 2,214,545 | — | — | 0 | Jun 16, 2020 | Jun 18, 2020 ↗ | View → |